Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

Share Price is delayed by 15 minutes
Get Live Data
98.90    -1.20 (-1.20%)
Bid:
99.22
Ask:
99.28
Spread: 0.06 (0.06%)
Market Cap: £57.64b
LLOY Live PriceLast checked at - London Stock Exchange

Intraday Lloyds Share Chart

Admission to Trading

16 Apr 2026 09:14

RNS Number : 7558A
Lloyds Banking Group PLC
16 April 2026
 

16 April 2026

Admission to Trading

In accordance with the Financial Conduct Authority's Prospectus Rules: Admission to Trading on a Regulated Market (PRM) sourcebook 1.5.2 and 1.5.3R, Lloyds Banking Group plc notifies the market that debt securities have been admitted to trading as follows:

 Issuer name:

Lloyds Banking Group plc

Issuer LEI:

549300PPXHEU2JF0AM85

Regulated market on which the securities have been admitted to trading:

Main Market for listed securities of the London Stock Exchange

Name, type and ISIN of the securities:

£500,000,000 5.625 per cent. Fixed Rate Reset Dated Subordinated Tier 2 Notes due 2036, ISIN XS3317581752

Number of securities admitted to trading:

£500,000,000 in aggregate nominal amount

Date of admission to trading:

16 April 2026

Date of Prospectus relating to the securities:

The base prospectus (the "Prospectus") under which the securities have been issued is available at: 

https://www.lloydsbankinggroup.com/assets/pdfs/investors/fixed-income-investors/unsecured-funding/lbg-lb-emtn-programme-2026/lbg-lb-emtn-prospectus-23mar26.pdf

 

For further information, please contact:

Investor Relations:

Douglas RadcliffeGroup Investor Relations DirectorTel: +44 (0) 20 7356 1571Email: douglas.radcliffe@lloydsbanking.com 

Group Corporate Affairs:

Matt SmithHead of Media RelationsTel: +44 (0) 7788 352 487Email: matt.smith@lloydsbanking.com

Lloyds Banking Group plcRegistered OfficeThe MoundEdinburgh EH1 1YZ

Disclaimer - Intended Addressees

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

EU MiFID II/UK MiFIR (Product Governance) - professionals and ECPs-only / No EU PRIIPs KID or UK PRIIPs KID/CCI product summary - Manufacturer target market (EU MiFID II product governance and UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No EU PRIIPs key information document (KID) or UK PRIIPs key information document (KID)/CCI product summary (as defined in the FCA Product Disclosure Sourcebook (DISC)) has been prepared as the Notes are not available to retail in the EEA or in the United Kingdom.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ADMIFMPTMTBBMJF
Date   Source Headline
28th Mar 20255:26 pmRNSTransaction in Own Shares
28th Mar 20252:16 pmRNSPublication of a Prospectus
27th Mar 20255:35 pmRNSTransaction in Own Shares
26th Mar 20255:36 pmRNSTransaction in Own Shares
25th Mar 20255:28 pmRNSTransaction in Own Shares
24th Mar 20255:35 pmRNSTransaction in Own Shares
24th Mar 20253:00 pmRNSDirector/PDMR Shareholding
21st Mar 20255:58 pmRNSTransaction in Own Shares
21st Mar 20254:27 pmRNSPublication of a Prospectus
20th Mar 20255:35 pmRNSTransaction in Own Shares
19th Mar 20255:53 pmRNSTransaction in Own Shares
19th Mar 202511:38 amRNSNotice of AGM
18th Mar 20255:33 pmRNSTransaction in Own Shares
17th Mar 20255:40 pmRNSTransaction in Own Shares
14th Mar 20255:53 pmRNSTransaction in Own Shares
13th Mar 20255:45 pmRNSTransaction in Own Shares
13th Mar 20254:00 pmRNSDirector/PDMR Shareholding
12th Mar 20255:44 pmRNSTransaction in Own Shares
11th Mar 20256:11 pmRNSTransaction in Own Shares
11th Mar 20254:31 pmRNSDirector/PDMR Shareholding
10th Mar 20255:48 pmRNSTransaction in Own Shares
10th Mar 20252:00 pmRNSDirector/PDMR Shareholding
7th Mar 20255:40 pmRNSTransaction in Own Shares
7th Mar 20252:00 pmRNSDirector/PDMR Shareholding
6th Mar 20255:45 pmRNSTransaction in Own Shares
6th Mar 20253:30 pmRNSDirector/PDMR Shareholding
5th Mar 20255:33 pmRNSTransaction in Own Shares
4th Mar 20255:54 pmRNSTransaction in Own Shares
4th Mar 20254:07 pmRNSPublication of Final Terms
3rd Mar 20255:39 pmRNSTransaction in Own Shares
28th Feb 20256:18 pmRNSTransaction in Own Shares
28th Feb 20252:40 pmRNSTotal Voting Rights
28th Feb 20251:21 pmRNSPublication of Suppl.Prospcts
28th Feb 202512:28 pmRNSPublication of Suppl.Prospcts
27th Feb 20256:16 pmRNSTransaction in Own Shares
27th Feb 20253:44 pmRNS2024 Form 20F Filed
27th Feb 20252:00 pmRNS2024 Annual Report and Accounts
27th Feb 20252:00 pmRNS2024 Annual Report and Accounts
27th Feb 20252:00 pmRNS2024 Annual Report and Accounts
27th Feb 202512:00 pmRNSDirector/PDMR Shareholding
27th Feb 20259:05 amRNS2024 Annual Report and Accounts
25th Feb 20256:22 pmRNSTransaction in Own Shares
24th Feb 20255:50 pmRNSTransaction in Own Shares
24th Feb 202512:27 pmRNSDirector/PDMR Shareholding
21st Feb 20255:56 pmRNSTransaction in Own Shares
21st Feb 202512:54 pmRNSPublication of Suppl.Prospcts
21st Feb 20257:10 amRNSCommencement of Share Buyback Programme
21st Feb 20257:00 amRNS2024 Form 20F Filed
20th Feb 20257:00 amRNS2024 Results
20th Feb 20257:00 amRNS2024 Annual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.